AKT1 and pancreatic neoplasm: Similar to our results with human pancreatic cancer cells, adaptation of murine PANC02 cells to toxic concentrations of AKT inhibitor led to recovery of proliferation, increased mitochondrial mass and enhanced sensitivity to metformin in vivo.